Yüklüyor......
Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases
Psoriasis is a chronic skin disease caused by the excessive secretion of inflammatory cytokines. Available therapeutic options include biologic drugs such as tumor necrosis factor alpha inhibitors and interleukin 12/23 (IL-12/23) inhibitors. The recent discovery of IL-17, which contributes to develo...
Kaydedildi:
| Yayımlandı: | Postepy Dermatol Alergol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Termedia Publishing House
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5004212/ https://ncbi.nlm.nih.gov/pubmed/27605893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2016.61599 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|